findmyKOL

Maria Alexianu, MD

Basic profile

Overlook Medical Center

ORCIDNone on fileNPI↗
✓ Full record
RegionHackensack, NJ · NortheastSpecialtyNeurologyFocusNeurology
Last active 2024findmyKOL type: RegionalLatest publication2014Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Maria Alexianu is a Neurology physician affiliated with Overlook Medical Center. OpenAlex indexes 22 publications with 2,000 citations (h-index 16).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
22publications

Distinct works indexed by OpenAlex.

2,000citations

Total citations across indexed works.

16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

30 Prospect Ave
Hackensack, NJ 076011915

Telephone

551-996-4078

Provider last certified this registry record 12 Feb 2026.

View the NPPES registry record

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    76.6%
    SSRI9.5%
    Trazodone Hcl32%Escitalopram Oxalate25%Sertraline Hcl25%Citalopram Hbr13%Fluoxetine Hcl5%
    Part D<11 patients
    Aromatic Amino Acid Decarboxylation Inhibitor9.3%
    Carbidopa-Levodopa71%Carbidopa-Levodopa Er24%Rytary6%
    Part D<11 patients

    + 21 more classes in this area

  • Musculoskeletal

    8.5%
    Muscle Relaxant3.8%
    Cyclobenzaprine Hcl78%Chlorzoxazone23%
    Part D<11 patients
    Central alpha-2 Adrenergic Agonist2.9%
    Tizanidine Hcl100%
    Part D≥17 patients

    + 2 more classes in this area

  • Blood & clotting

    3.8%
    P2Y12 inhibitor3.3%
    Clopidogrel80%Brilinta20%
    Part D<11 patients
    Salt solutions0.5%
    Sodium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)14.6% facility · 85.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”